2.1900
-0.0200
(-0.90%)
As of 12:56:05 PM GMT+1. Market Open.
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Operating Cash Flow
-23,806.0000
-23,806.0000
-22,993.0000
-22,218.0000
-17,479.0000
Investing Cash Flow
-123.0000
-123.0000
-385.0000
-473.0000
-142.0000
Financing Cash Flow
23,983.0000
23,983.0000
23,478.0000
25,590.0000
14,787.0000
End Cash Position
6,876.0000
6,876.0000
6,990.0000
6,853.0000
4,108.0000
Capital Expenditure
-123.0000
-123.0000
-385.0000
-474.0000
-142.0000
Issuance of Capital Stock
26,031.0000
26,031.0000
13,445.0000
25,559.0000
14,103.0000
Issuance of Debt
64.0000
64.0000
10,389.0000
662.0000
630.0000
Repayment of Debt
-861.0000
-861.0000
-105.0000
-122.0000
-122.0000
Free Cash Flow
-23,929.0000
-23,929.0000
-23,378.0000
-22,692.0000
-17,621.0000
12/31/2020 - 1/21/2019
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
CVAC.VI CureVac N.V.
3.6080
-3.84%
BT3.BE Lineage Cell Therapeutics Inc
0.5850
0.00%
1GDA.F Zevra Therapeutics, Inc.
7.40
-3.27%
471A.F aTyr Pharma, Inc.
3.4200
+1.18%
HQ1.MU Oruka Therapeutics Inc. R
11.80
-3.28%
2Q5.BE Enochian BioSciences Inc
0.8460
-0.24%
ORN.F Oryzon Genomics S.A.
1.4660
+3.97%
PH4.F CStone Pharmaceuticals
0.2860
0.00%
ANNX.ST Annexin Pharmaceuticals AB (publ)
0.4700
-3.09%
25I.F ImmuPharma plc
0.0605
+168.89%